As of Oct 27
| +0.10 / +2.05%|
The 4 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 12.50, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +151.00% increase from the last price of 4.98.
The current consensus among 4 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.